TP53 and acute myeloid leukemia: Homozygous R178E mice succumbed to spontaneous cancer with similar disease latency and penetrance as p53 knock-out mice, which was also true for Eμ-Myc-induced lymphoma and acute myeloid leukemia (AML) driven by AML1/ETO9a and NrasG12D.